In vitro effects of ascorbic acid on viability and metabolism of patients’ osteosarcoma stem cells
References
- 1. J. K. Anninga, H. Gelderblom, M. Fiocco, J. R. Kroep, A. H. Taminiau, P. C. Hogendoorn and R. M. Egeler, Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?, Eur. J. Cancer 47(16) (2011) 2431–2445; https://doi.org/10.1016/j.ejca.2011.05.030
- 2. C. P. Gibbs, P. P. Levings and S. C. Ghivizzani, Evidence for the osteosarcoma stem cell, Current Orthopaedic Practice 22(4) (2011) 322–326; https://doi.org/10.1097/BCO.0b013e318221aee8
- 3. D. Nassar and C. Blanpain, Cancer stem cells: Basic concepts and therapeutic implications, Annu. Rev. Pathol. 23(11) (2016) 47–76; https://doi.org/10.1146/annurev-pathol-012615-044438
- 4. M. Jang, S. S. Kim and J. Lee, Cancer cell metabolism: implications for therapeutic targets, Exp. Mol. Med. 45(10) (2013) Article ID 201385 (8 pages); https://doi.org/10.1038/emm.2013.85
- 5. M. G. Vander Heiden, L. C. Cantley and C. B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science 324(5930) (2009) 1029–1033; https://doi.org/10.1126/science.1160809
- 6. H. Kondoh, M. E. Lleonart, D. Bernard and J. Gil, Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization, Histol. Histopathol. 22(1) (2007) 85–90; https://doi.org/10.14670/HH-22.85
- 7. C. D. Folmes, T. J. Nelson, A. Martinez-Fernandez, D. K. Arrell, J. Z. Lindor, P. P. Dzeja, Y. Ikeda, C. Perez-Terzic and A. Terzic, Somatic oxidative bioenergetics transitions into pluripotency dependent glycolysis to facilitate nuclear reprogramming, Cell. Metab. 14(2) (2011) 264–271; https://doi.org/10.1016/j.cmet.2011.06.011
- 8. G. Farnie, F. Sotgia and M. P. Lisanti, High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant, Oncotarget 6(31) (2015) 30472–30486; https://doi.org/10.18632/oncotarget.5401
- 9. A. De Luca, M. Fiorillo, M. Peiris-Pagès, B. Ozsvari, D. L. Smith, R. Sanchez-Alvarez, U. E. Martinez-Outschoorn, A. R. Cappello, V. Pezzi, M. P. Lisanti and F. Sotgia, Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells, Oncotarget 6(17) (2015) 14777–14795; https://doi.org/10.18632/oncotarget.4401
- 10. P. Sancho, D. Barneda and C. Heeschen, Hallmarks of cancer stem cell metabolism, Br. J. Cancer 114(12) (2016) 1305–1312; https://doi.org/10.1038/bjc.2016.152
- 11. V. Snyder, T. C. Reed-Newman, L. Arnold, S. M. Thomas and S. Anant, Cancer stem cell metabolism and potential therapeutic targets, Front. Oncol. 203(8) (2018) Article ID e203 (9 pages); https://doi.org/10.3389/fonc.2018.00203
- 12. J. He, L. Xiong, Q. Li, L. Lin, X. Miao, S. Yan, Z. Hong, L. Yang, Y. Wen and X. Deng, 3D modeling of cancer stem cell niche, Oncotarget 9(1) (2017) 1326–1345; https://doi.org/10.18632/oncotarget.19847
- 13. S. Park, S. Ahn, Y. Shin, Y. Yang and C. H. Yeom, Vitamin C in cancer: A metabolomics perspective, Front. Physiol. 762(9) (2018) Article ID e762 (9 pages); https://doi.org/10.3389/fphys.2018.00762
- 14. N. J. Satheesh, S. M. Samuel and D. Büsselberg, Combination therapy with vitamin C could eradicate cancer stem cells, Biomolecules 10(1) (2020) Article ID 1000079 (20 pages); https://doi.org/10.3390/biom10010079
- 15. M. T. Valenti, M. Zanatta, L. Donatelli, G. Viviano, C. Cavallini, M. T. Scupoli and L. Dalle Carbonare, Ascorbic acid induces either differentiation or apoptosis in MG-63 osteosarcoma lineage, Anticancer Res. 34(4) (2014) 1617–1627.
- 16. G. Fernandes, A. W. Barone and R. Dziak, The effect of ascorbic acid on bone cancer cells in vitro, Cogent Biol. 3(1) (2017) Article ID 1288335 (12 pages); https://doi.org/10.1080/23312025.2017.1288335
- 17. S. J. Lee, J. H. Jeong, I. H. Lee, J. Lee, J. H. Jung, H. Y. Park, D. H. Lee and Y. S. Chae, Effect of high-dose vitamin C combined with anti-cancer treatment on breast cancer cells, Anticancer Res. 39(2) (2019) 751–758; https://doi.org/10.21873/anticanres.13172
- 18. J. Kaźmierczak-Barańska, K. Boguszewska, A. Adamus-Grabicka and B. T. Karwowski, Two faces of vitamin C – antioxidative and pro-oxidative agent, Nutrients 12(5) (2020) Article ID1201501 (19 pages); https://doi.org/10.3390/nu12051501
- 19. K. F. Hung, T. Yang and S. Y. Kao, Cancer stem cell theory: Are we moving past the mist?, J. Chin. Med. Assoc. 82(11) (2019) 814–818; https://doi.org/10.1097/JCMA.0000000000000186
- 20. Z. Zhong, S. Mao, H. Lin, H. Li, J. Lin and J. M. Lin, Alteration of intracellular metabolome in osteosarcoma stem cells revealed by liquid chromatography-tandem mass spectrometry, Talanta 204 (2019) 6–12; https://doi.org/10.1016/j.talanta.2019.05.088
- 21. E. Mizushima, T. Tsukahara, M. Emori, K. Murata, A. Akamatsu, Y. Shibayama, S. Hamada, Y. Watanabe, M. Kaya, Y. Hirohashi, T. Kanaseki, M. Nakatsugawa, T. Kubo, T. Yamashita, N. Sato and T. Torigoe, Osteosarcoma-initiating cells show high aerobic glycolysis and attenuation of oxidative phosphorylation mediated by LIN28B, Cancer science 111(1) (2020) 36–46; https://doi.org/10.1111/cas.14229
- 22. G. Palmini, R. Zonefrati, C. Mavilia, A. Aldinucci, E. Luzi, F. Marini, A. Franchi, R. Capanna, A. Tanini and M. L. Brandi, Establishment of cancer stem cell cultures from human conventional osteosarcoma, J. Vis. Exp. 116 (2016) Article ID e53884 (17 pages); https://doi.org/10.3791/53884
- 23. S. H. Bae, H. Ryu, K. J. Rhee, J. E. Oh, S. K. Baik, K. Y. Shim, J. H. Kong, S. Y. Hyun, H. S. Pack, C. Im, H. C. Shin, Y.M. Kim, H. S. Kim, Y. W. Eom and J. I. Lee, L-ascorbic acid 2-phosphate and fibroblast growth factor-2 treatment maintains differentiation potential in bone marrow-derived mesenchymal stem cells through expression of hepatocyte growth factor, Growth Factors 33(2) (2015) 71–78; https://doi.org/10.3109/08977194.2015.1013628
Language: English
Page range: 599 - 613
Accepted on: Jul 19, 2022
Published on: Oct 18, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2022 Marijana Šimić Jovičić, Maja Pušić, Maja Antunović, Maja Ledinski, Lucija Librenjak, Robert Kolundžić, Tomislav Ribičić, Vladimir Trkulja, Inga Urlić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.